Search Results
Prescient Therapeutics (ASX: PTX): PTX-100 targeted cell therapy briefing - 2 March 2023
Prescient Therapeutics (ASX: PTX) Investor Briefing - 26 November 2019
Antisense Therapeutics Presentation - NWR Virtual Small Cap Investor Conference, Series 2
